Treatment of cancer with immune stimulators
AssigneeSciclone Pharmaceuticals International (Sg) Pte. Ltd.
InventorsRobert S. King, Cynthia W. Tuthill, Friedhelm Blobel
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
Claims10
A method of treating cancer or a metastasis thereof in a subject comprising administering a therapeutically effective amount of an alpha thymosin peptide and a therapeutically effective amount of a checkpoint protein inhibitor, wherein the cancer is melanoma.
A method of treating cancer or a metastasis thereof in a subject comprising administering a therapeutically effective amount of an alpha thymosin peptide, wherein the subject has been administered with a therapeutically effective amount of a checkpoint protein inhibitor, wherein the cancer is melanoma.
Dependencies are inferred from the claim text.